Home/Filings/4/0001104659-25-012903
4//SEC Filing

Mekhail Adel 4

Accession 0001104659-25-012903

CIK 0001295947other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:01 PM ET

Size

15.6 KB

Accession

0001104659-25-012903

Insider Transaction Report

Form 4
Period: 2025-02-11
Mekhail Adel
EVP, Marketing & Sales
Transactions
  • Sale

    Common Stock, par value $0.01 per share

    2025-02-11$86.82/sh5,400$468,82818,365 total
  • Exercise/Conversion

    Employee Stock Options (rights to buy)

    2025-02-115,4000 total
    Exercise: $44.33Exp: 2031-05-03Common Stock (5,400 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.01 per share

    2025-02-11$54.47/sh+5,683$309,55324,048 total
  • Sale

    Common Stock, par value $0.01 per share

    2025-02-11$86.30/sh5,683$490,44318,365 total
  • Exercise/Conversion

    Employee Stock Options (rights to buy)

    2025-02-115,6832,842 total
    Exercise: $54.47Exp: 2032-05-02Common Stock (5,683 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.01 per share

    2025-02-11$44.33/sh+5,400$239,38223,765 total
Footnotes (4)
  • [F1]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $86.00 to $86.82.
  • [F2]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $86.00 to $86.30.
  • [F3]The options vested in three equal installments of 3,655 shares on May 4, 2021, May 4, 2022 and May 4, 2023.
  • [F4]The options vests in three equal installments of 2,841 shares each on May 2,2023 and 2,842 shares each on May 3, 2024 and May 3, 2025

Issuer

Prestige Consumer Healthcare Inc.

CIK 0001295947

Entity typeother

Related Parties

1
  • filerCIK 0001776953

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:01 PM ET
Size
15.6 KB